©The Author(s) 2025.
World J Gastrointest Surg. Jan 27, 2025; 17(1): 97148
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148
Published online Jan 27, 2025. doi: 10.4240/wjgs.v17.i1.97148
Table 3 Antibody information
| Antibody | Manufacturer | No. | Dilution ratio |
| AURKA antibody | Affinity | BF0123 | 1:2000 |
| TPX2 antibody | Abcam | ab264124 | 1:5000 |
| Cyclin B1 antibody | Affinity | AF6168 | 1:2000 |
| CDK1 antibody | Abcam | ab133327 | 1:15000 |
| CDK2 antibody | Affinity | AF6237 | 1:2000 |
| Bax antibody | Abcam | ab182733 | 1:2000 |
| Bcl-2 antibody | Affinity | AF6139 | 1:2000 |
| Caspase-3 antibody | Proteintech | 19677-1-AP | 1:10000 |
| p53 antibody | Affinity | AF0879 | 1:2000 |
| N-cadherin antibody | Affinity | AF4039 | 1:2000 |
| E-cadherin antibody | Proteintech | 20874-1-AP | 1:5000 |
| Vimentin antibody | Zenbio | R22775 | 1:1000 |
| p-AURKA antibody | Affinity | AF3011 | 1:2000 |
| β-actin antibody | Proteintech | 81115-1-RR | 1:20000 |
| Anti-rabbit IgG, HRP-linked antibody | CST | 7074 | 1:10000 |
- Citation: Sheng GX, Zhang YJ, Shang T. Synergistic inhibition of colorectal cancer progression by silencing Aurora A and the targeting protein for Xklp2. World J Gastrointest Surg 2025; 17(1): 97148
- URL: https://www.wjgnet.com/1948-9366/full/v17/i1/97148.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i1.97148